Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Neurosciences: early-phase trial registry

1 of 2 indexed Neurosciences trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Neurosciences: 2 US clinical trials tracked, 1 recruiting.

Neurosciences is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Michael J. Wesley, PhD, running 1 of these trials.

Enrollment posture brief

Registry condition neurosciences

OPEN 1 | RECR 50% | LATE 0 | EARLY 1 | RANK #7188 | SPON 1

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Neurosciences (this)50%
Open-enrollment share among volume-matched conditions near Neurosciences

Neurosciences lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Neurosciences on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Neurosciences is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Named interventions

Most-linked intervention names on Neurosciences records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Marinol 10Mg Capsule TMS Real Other
1 trials
Placebo TMS Real Device
1 trials
Marinol 30Mg Capsule TMS Sham Drug
1 trials
Marinol 10Mg Capsule TMS Sham Drug
1 trials
Placebo TMS Sham Device
1 trials
Behavioral testing during neuronal recordings Behavioral
1 trials

US sites by state

Facility locations filed on Neurosciences trials. A trial with sites in several states counts in each.

Rhode Island 1 trials
Massachusetts 1 trials
Kentucky 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Neurosciences page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Neurosciences condition card totals 2 registered trials; most-linked intervention Marinol 10Mg Capsule TMS Real; top US site state Rhode Island. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.